Cannabis Can Improve Insomnia, Depression and Anxiety

According to a research published in BMC Psychiatry, many persons with depression and anxiety believe that Cannabis has a good effect on their ability to sleep. The current study’s authors claim that the results show the need of conducting placebo-controlled studies to determine if might reduce the symptoms of insomnia.Sleep problems are a typical sign of mental diseases and may be quite upsetting for the affected individual.

As a result, insomnia can make depression symptoms worse and trap sufferers in a vicious cycle that is hard to break. Even though this problem is quite common, there aren’t many treatments for insomnia. has gained popularity in recent years due to its medicinal advantages, which include its ability to promote sleep. There is conflicting evidence from earlier studies on whether Cannabis can reduce anxiety and increase sleep, or if these effects are the result of other factors that were being examined. The purpose of this study is to determine whether Cannabis does, in fact, help patients with anxiety and/or depression sleep better.

Data from 100 people with depression, 463 adults with anxiety, and 114 persons with both were evaluated by study author Nirushi Kuhathasan and her colleagues. Participants’ progress was monitored between February 2017 and February 2020. Participants kept track of their Cannabis use and their symptoms of sleeplessness using an app. The participants also provided demographic data. According to the findings, indica and CBD-dominant strains were more frequently utilised to treat sleeplessness in depressed individuals throughout sessions. The most popular strains among those who had anxiety or both depression and anxiety were indica and indica hybrids.

The majority of individuals utilised dried Cannabis flowers.Under-45-year-old individuals in the depressed condition appeared to benefit greatly from, but this effect was less pronounced for people in this age range. usage seemed to reduce anxiety-related symptoms for individuals of all ages, with the 35–44 age group reporting greater advantages than the 25–34 group. was helpful for all ages in the comorbidity group of individuals who had both anxiety and depression.